drugset
drugset / Trial / NCT03049293

Measurement of Midazolam Levels in Follicular Fluid

NCT03049293 ↗

Phase 0 Terminated 30 enrolled ART Fertility Clinics LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the impact of Midazolam levels in follicular fluid on morpho-kinetics and morpho-genetics. The reason to measure Midazolam levels in larger size follicles in this study is to maximize the chances to get a mature oocyte and therefore develop into a potential embryo to be analyzed.

Timeline

Start
2017-06-20
Primary completion
2019-10-01
Completion
2019-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 1 mg —

Indications

No indication recorded.